Efficacy of parenteral methotrexate in refractory Crohn's disease

Alimentary Pharmacology and Therapeutics

Volumn 15, Issue 1, 2001, Pages 35-44

  Chong, R Y ^a   Hanauer, S B ^b   Cohen, R D ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE; PREDNISONE;

ADULT; AGED; ARTICLE; COLON CROHN DISEASE; DRUG EFFICACY; DRUG TOLERANCE; FATIGUE; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PARESTHESIA; PRIORITY JOURNAL; TREATMENT OUTCOME; VOMITING;

ADMINISTRATION, ORAL; ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; ANTI-BACTERIAL AGENTS; CROHN DISEASE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS; MALE; METHOTREXATE; MIDDLE AGED;

EID: 0035176366     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2001.00908.x     Document Type: Article

References (26)

1. European Cooperative Crohn's Disease Study (ECCDS): Results of drug treatment
2. National Cooperative Crohn's Disease Study: Results of drug treatment
3. Frequency of glucocorticoid resistance and dependency in Crohn's disease
4. Glucocorticoid-induced osteoporosis: Pathogenesis and management
5. Corticosteroid-induced osteoporosis
6. The efficacy and safety of low-dose corticosteroids for rheumatoid arthritis
7. Corticosteroid treatment for inflammatory bowel disease in pediatric patients increases intraocular pressure
8. Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease
9. Treatment of refractory Crohn's disease with methotrexate
10. Low-dose oral methotrexate in refractory inflammatory bowel disease
11. Methotrexate in Crohn's disease: Results of a randomized, double-blind, placebo-controlled trial
12. Methotrexate for the treatment of Crohn's disease
13. Methotrexate in chronic active Crohn's disease: A double-blind, randomized, Israeli multicenter trial
14. A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North America Crohn's Study Group Investigators
15. Methotrexate in Crohn's disease: Long-term efficacy and toxicity
16. Methotrexate in Crohn's disease: Long term efficacy and toxicity
17. Long-term use of methotrexate in inflammatory bowel disease: Severe disease 3, drug therapy 2. seventh inning stretch
18. The place for methotrexate in the treatment of refractory Crohn's disease
19. Methotrexate in refractory Crohn's disease
20. Methotrexate for inflammatory bowel disease: Pharmacology and preliminary results
21. The role of methotrexate therapy in the management of patients with cyclosporine A-resistant inflammatory bowel disease
22. Methotrexate for the treatment of refractory Crohn's disease
23. Methotrexate in patients with Crohn's disease after 6 mercaptopurine
24. Efficacy and safety of subcutaneous methotrexate in Crohn's disease
25. Methotrexate therapy in children with severe Crohn's disease: Preliminary results
26. Hepatic effects of long-term methotrexate therapy of inflammatory bowel disease